A phase 3 randomized study to evaluate safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in healthy Japanese infants

Objectives: Safety and immunogenicity evaluation of a 4-dose series with 20-valent pneumococcal conjugate vaccine (PCV20). Methods: This phase 3, double-blind study randomized healthy Japanese infants to receive 4 doses (3 infant doses, 1 toddler dose) of PCV20 by subcutaneous (SC) or intramuscular...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yasunori Ishihara, Mitsuru Fukazawa, Shinya Enomoto, Richard de Solom, Masako Yamaji, Mary Kline, Masakazu Aizawa, Yahong Peng, Osamu Kogawara, Peter C. Giardina, Noor Tamimi, William C. Gruber, Wendy Watson
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2024-04-01
Serie:	International Journal of Infectious Diseases
Soggetti:	20-valent pneumococcal conjugate vaccine Immunogenicity Infants Safety Japan
Accesso online:	http://www.sciencedirect.com/science/article/pii/S1201971224000109
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!